Climb Bio EPS CLYM

Diluted earnings per share by quarter and over the last twelve months, from 2020.

Climb Bio's earnings per share was −$0.83 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.18.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$0.18	n/a	−$0.83
Q1 FY26	Mar 31, 2026	−$0.20	n/a	−$0.78
Q4 FY25	Dec 31, 2025	−$0.26	n/a	−$0.89
Q3 FY25	Sep 30, 2025	−$0.19	n/a	−$0.76
Q2 FY25	Jun 30, 2025	−$0.13	n/a	−$0.70
Q1 FY25	Mar 31, 2025	−$0.31	n/a	−$2.38
Q4 FY24	Dec 31, 2024	−$0.13	n/a	−$2.13
Q3 FY24	Sep 30, 2024	−$0.13	n/a	−$2.13
Q2 FY24	Jun 30, 2024	−$1.81	n/a	−$2.15
Q1 FY24	Mar 31, 2024	−$0.06	n/a	−$0.53
Q4 FY23	Dec 31, 2023	−$0.13	n/a	−$1.31
Q3 FY23	Sep 30, 2023	−$0.15	n/a	−$1.47

Companies in Drug Manufacturers - General nearest Climb Bio's size, closest first, today.

Company	EPS, 12 months	Growth
CLYMClimb Bio	−$0.83
ZVRAZevra Therapeutics	$0.93
IRWDIronwood Pharmaceuticals	$0.77
PBYIPuma Biotechnology	$0.52	−47% a year
CRMDCorMedix	$2.13	+184% a year
ARVNArvinas	$0.16
COLLCollegium Pharmaceutical	$1.24	+19% a year
ABUSArbutus Biopharma	$0.78
AMPHAmphastar Pharmaceuticals	$1.70	−36% a year
OMEROmeros	$1.52
PCRXPacira BioSciences	$0.35
Peer median	$0.85